Pangenotypic Hepatitis C Therapy with Direct Acting Antivirals: A Southern Nigeria Pilot Experience
Abere Sarah, Oyan Boma, Kooffreh-Ada Mbang & Ijoma Uchenna · Asian Journal of Research in Infectious Diseases · 2022
Background: Viral hepatitis C (HCV) is a global health challenge affecting at least 3.3% of the world population. Sub-Saharan Africa still battles with under diagnosis, and poor access to diagnostic facilities occasioned by a lack of manpower/facilities to treat infected persons...
Open access
Research Article
10.9734/ajrid/2022/v10i430297